Announcements Trials

Browse Landscape Eligibility

Clinical Trials

0 trials

Recent Start date Enrollment

Has results × Mesothelioma, Malignant × enzalutamide × Clear all

Sponsor

Conditions

Prostatic Neoplasms 59 Breast Neoplasms 9 Neoplasm Metastasis 7 Prostatic Neoplasms, Castration-Resistant 6 Neoplasms 4 Prostate Cancer Metastatic 3 Parkinson Disease 4, Autosomal Dominant Lewy Body 3 Metastatic Castration-resistant Prostate Cancer 3 Triple Negative Breast Neoplasms 2 Squamous Cell Carcinoma of Head and Neck 2 Metastatic Hormone Sensitive Prostate Cancer 2 Metastatic Castration Resistant Prostate Cancer 2 Melanoma 2 mCRPC 1 Urinary Bladder Neoplasms 1 Urinary Bladder Diseases 1 Urethral Neoplasms 1 Ureteral Neoplasms 1 Ureteral Diseases 1 Small Cell Lung Carcinoma 1 Seizures 1 Salivary Cancer 1 Recurrent Endometrial Endometrioid Adenocarcinoma 1 Pancreatic Neoplasms 1 Neoplasms, Squamous Cell 1 Metastatic Progressive Castration-resistant Prostate Cancer 1 Metastatic Castration-Resistant Prostate Cancer 1 Metastatic Castrate-Resistant Prostate Cancer 1 Mesothelioma 1 Lymphoma, Mantle-Cell 1

Interventions

Pemetrexed 14 Cisplatin 13 pembrolizumab 4 Platinum 4 1,2-diaminocyclohexaneplatinum II citrate 4 Radiotherapy 3 Gemcitabine 3 Carboplatin 3 cediranib 2 amatuximab 2 Radiotherapy, Intensity-Modulated 2 Radiation 2 Drug Therapy 2 Cyclophosphamide 2 tumor necrosis factor-alpha, CNGRC fusion protein, human 1 tremelimumab 1 sodium thiosulfate 1 sargramostim 1 nintedanib 1 napabucasin 1 methoxyamine 1 liposomal doxorubicin 1 incomplete Freund's adjuvant 1 fresolimumab 1 durvalumab 1 defactinib 1 cixutumumab 1 bintrafusp alfa protein, human 1 bemcentinib 1 belinostat 1

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

No trials found.

Data powered by HemOnc (CC BY 4.0) Colophon ⚡